
Digistain
Digistain
Claim
50% of women with breast cancer suffer through expensive and potentially lethal chemotherapy they don't need. Digistain solves this problem by scanning biopsies in the infrared to measure the increase in cancerous DNA.50% of women with breast cancer suffer through expensive and potentially lethal chemotherapy they do Show More
Alpha Score
$ 31.04 M
Alpha Score
51.5
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0